Page last updated: 2024-11-05

ortho-hydroxybenzophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ortho-hydroxybenzophenone (OHBP) is an organic compound with the formula C13H10O2. It is a white solid that is soluble in organic solvents. OHBP is a valuable intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also an important UV absorber and is used in sunscreens and other personal care products. The synthesis of OHBP involves the Friedel-Crafts acylation of phenol with benzoyl chloride. The compound is also known to have antioxidant properties and has been shown to protect cells from oxidative stress. Its photochemical properties make it an interesting molecule for studies in the field of photochemistry and photobiology. OHBP is a valuable molecule for research and development in various areas of chemistry, medicine, and materials science.'

ortho-hydroxybenzophenone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hydroxybenzophenone : Any benzophenone into which is substituted one or more hydroxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8348
CHEMBL ID24743
SCHEMBL ID36215
MeSH IDM0562391

Synonyms (53)

Synonym
OPREA1_210355
inchi=1/c13h10o2/c14-12-9-5-4-8-11(12)13(15)10-6-2-1-3-7-10/h1-9,14
phenyl 2-hydroxyphenyl ketone
o-benzoylphenol
o-hydroxybenzophenone
nsc-623
methanone, (2-hydroxyphenyl)phenyl-
2-hydroxybenzophenone
nsc623
benzophenone, 2-hydroxy-
117-99-7
2-hydroxybenzophenone, 99%
CHEMBL24743
(2-hydroxyphenyl)-phenylmethanone
H0470
2-benzoylphenol
NCGC00248688-01
AKOS009156814
einecs 204-226-2
lqv22w4v05 ,
2'-hydroxybenzophenone
unii-lqv22w4v05
nsc 623
cas-117-99-7
tox21_303440
NCGC00257431-01
dtxcid5027855
dtxsid5047879 ,
NCGC00258095-01
tox21_200541
FT-0612584
(2-hydroxyphenyl)(phenyl)methanone
AE-562/43458976
SCHEMBL36215
hydroxybenzophenone
2-hydroxy-benzophenone
2-hydroxybenzop he none
(2-hydroxy-phenyl)-phenyl-methanone
2-hydroxyphenyl phenyl methanone
W-108554
ortho-hydroxybenzophenone
(2-hydroxyphenyl)phenylmethanone
o-hydroxyphenyl phenyl ketone
mfcd00002216
methanone, (hydroxyphenyl)phenyl-
CS-0134078
SY010786
DS-6485
Q27283134
2-hydroxy benzophenone
W18696
EN300-37134
Z381040336
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency72.77860.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency22.22040.006038.004119,952.5996AID1159521
AR proteinHomo sapiens (human)Potency29.73310.000221.22318,912.5098AID1259243; AID1259247; AID743036
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency17.65030.001022.650876.6163AID1224838; AID1224893
estrogen nuclear receptor alphaHomo sapiens (human)Potency31.69720.000229.305416,493.5996AID1259244; AID743069
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency27.30600.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency0.002219.739145.978464.9432AID1159509
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency27.97380.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency27.97380.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID76560Inhibition of slow reacting substance of anaphylaxis (SRS-A) release from sensitized guinea pig chopped lung upon antigen challenge at 10 ug/mL1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Antianaphylactic benzophenones and related compounds.
AID78053Inhibition of histamine release from sensitized guinea pig chopped lung, upon antigen challenge at 10 ug/mL.1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Antianaphylactic benzophenones and related compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (81.82)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.84 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]